IBIO
IBIO
NASDAQ · Biotechnology

Ibio Inc

$1.41
+0.02 (+1.44%)
As of Aug 8, 10:46 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +904.3% upside
Low Target $9.87
Average Target $14.16
High Target $18.59
Current Price $1.41
Current
$1.41
Target
$14.16
$9.87 $14.16 avg $18.59
Scenario Analysis
Bear Case
$9.87
600.0%
Low target
Base Case
$14.16
+904.3%
Avg target
Bull Case
$18.59
+1,218.4%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$3.82
-63.1% from high
52-Week Low
$0.56
+153.5% from low
Target vs 52W High
$14.16
+270.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.0%